Serum Scores A Double - HPV Vaccine In India, Novavax Vaccine In US
Demand High For HPV, Low For COVID-19 Vaccine
Serum Institute will supply initial doses of NVX-CoV2373 in the US, but late approvals have meant Novavax's vaccine is facing weak demand and surplus stocks in other parts of the world. Meanwhile, Serum has also secured a nod in India for the first indigenously-developed HPV vaccine, also the fifth globally.
